293 related articles for article (PubMed ID: 35219932)
21. Microvascular Thrombosis as a Critical Factor in Severe COVID-19.
Wadowski PP; Panzer B; Józkowicz A; Kopp CW; Gremmel T; Panzer S; Koppensteiner R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768817
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 versus HIT hypercoagulability.
Warkentin TE; Kaatz S
Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic risk in patients with COVID-19.
Pancaldi E; Pascariello G; Cimino G; Cersosimo A; Amore L; Alghisi F; Bernardi N; Calvi E; Lombardi CM; Vizzardi E; Metra M
Rev Cardiovasc Med; 2021 Jun; 22(2):277-286. PubMed ID: 34258896
[TBL] [Abstract][Full Text] [Related]
24. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
[TBL] [Abstract][Full Text] [Related]
25. Congenital Bleeding Disorders and COVID-19 - An Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19.
Dorgalaleh A; Narouei F; Asadi M; Khamsi HM; Gholami MS
Cardiovasc Hematol Disord Drug Targets; 2022; 22(2):83-86. PubMed ID: 35702769
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.
Ward A; Sarraju A; Lee D; Bhasin K; Gad S; Beetel R; Chang S; Bonafede M; Rodriguez F; Dash R
PLoS One; 2022; 17(1):e0261786. PubMed ID: 35020742
[TBL] [Abstract][Full Text] [Related]
27. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.
Goswami J; MacArthur TA; Sridharan M; Pruthi RK; McBane RD; Witzig TE; Park MS
Shock; 2021 Jun; 55(6):700-716. PubMed ID: 33378321
[TBL] [Abstract][Full Text] [Related]
28. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of thrombosis and cardiovascular complications in COVID-19.
Page EM; Ariëns RAS
Thromb Res; 2021 Apr; 200():1-8. PubMed ID: 33493983
[TBL] [Abstract][Full Text] [Related]
30. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.
Zanza C; Racca F; Longhitano Y; Piccioni A; Franceschi F; Artico M; Abenavoli L; Maiese A; Passaro G; Volonnino G; La Russa R
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572570
[TBL] [Abstract][Full Text] [Related]
31. Coagulation abnormalities & thromboprophylaxis in COVID-19.
Jandial A; Gupta A; Malviya A; Agastam S; Kumar D
Indian J Med Res; 2021 May&Jun; 153(5&6):606-618. PubMed ID: 34643567
[TBL] [Abstract][Full Text] [Related]
32. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
Gorog DA; Storey RF; Gurbel PA; Tantry US; Berger JS; Chan MY; Duerschmied D; Smyth SS; Parker WAE; Ajjan RA; Vilahur G; Badimon L; Berg JMT; Cate HT; Peyvandi F; Wang TT; Becker RC
Nat Rev Cardiol; 2022 Jul; 19(7):475-495. PubMed ID: 35027697
[TBL] [Abstract][Full Text] [Related]
33. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management.
Zhou X; Cheng Z; Hu Y
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945800
[TBL] [Abstract][Full Text] [Related]
35. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
Rodriguez JJ; Munoz OC; Porres-Aguilar M; Mukherjee D
Cardiovasc Hematol Disord Drug Targets; 2021; 21(1):23-29. PubMed ID: 33719953
[TBL] [Abstract][Full Text] [Related]
36. Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.
Di Micco P; Imparato M; Lubrano G; Iannuzzo D; Fontanella L; Improta L; Poggiano MR; Salzano C; Rodolico A; Fontanella A
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33498929
[TBL] [Abstract][Full Text] [Related]
37. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches.
Correale M; Tricarico L; Fortunato M; Dattilo G; Iacoviello M; Brunetti ND
Aging Clin Exp Res; 2021 Feb; 33(2):273-278. PubMed ID: 33449336
[TBL] [Abstract][Full Text] [Related]
38. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Expert Rev Respir Med; 2021 Aug; 15(8):1003-1011. PubMed ID: 33667146
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.
Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K
Br J Haematol; 2020 Aug; 190(4):529-532. PubMed ID: 32621757
[TBL] [Abstract][Full Text] [Related]
40. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
